Physician

Jonathan D Siegel, MD

According to 2025 Medicare claims, Jonathan Siegel, MD (NPI: 1639110224) practices gastroenterology in the Mobile, AL market, with the plurality of this provider's patient population coming from Mobile, AL. This provider's primary affiliated billing organization is GUT PC (NPI: 1073566006; TIN: 20-2904686) and primary practice location at 36608-1263. Siegel is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Siegel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 518 traditional Medicare patients, billed 8,283 HCPCS/CPT codes, and received $248,635 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 5,316 prescription claims across 1,389 beneficiaries totaling $4,663,202 in drug costs, led by Stelara (Ustekinumab). Open Payments data shows 216 records totaling $313,146. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $391,666 to $248,635. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $2,002,760 and ending at $4,663,202. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	757	5,459	$391,666
2016	727	12,814	$528,946
2017	527	15,084	$459,493
2018	561	13,962	$453,216
2019	631	26,730	$562,117
2020	468	24,332	$440,438
2021	441	10,488	$276,554
2022	468	9,880	$298,461
2023	496	10,804	$315,377
2024	518	8,283	$248,635

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	755	2,810	$2,002,760
2016	801	2,989	$2,584,360
2017	818	2,721	$1,174,273
2018	982	3,072	$1,470,826
2019	970	3,019	$1,300,332
2020	879	2,848	$775,111
2021	1,015	3,011	$1,226,619
2022	1,112	3,666	$2,014,740
2023	1,240	4,545	$4,352,687
2024	1,389	5,316	$4,663,202

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	115	117	$192
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	88	131	$123
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	121	121	$103
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	268	378	$86
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	129	140	$58

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Stelara	Ustekinumab	62	2,270	$1,659,447
Entyvio	Vedolizumab	107	3,808	$921,889
Skyrizi On-Body	Risankizumab-Rzaa	18	1,008	$376,345
Linzess	Linaclotide	399	21,120	$370,011
Xifaxan	Rifaximin	54	1,508	$166,787

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	177	$2,832	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	39	$310,314	Genentech, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jonathan D. Siegel, MD?

Tedicare shows public-source Medicare data for Jonathan D. Siegel, MD (NPI 1639110224), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jonathan D. Siegel, MD have ACO affiliation data?

Jonathan D. Siegel, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Jonathan D. Siegel, MD?

Jonathan D. Siegel, MD is linked to GUT PC (billing NPI 1073566006) in the available physician profile data.

Does Jonathan D. Siegel, MD have Open Payments data?

Jonathan D. Siegel, MD has 216 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.